3004.90.92.32 - Other 🖩
Details
| Field | Value |
|---|---|
| Unit of Quantity | kg |
| General Rate of Duty (Column 1 - General) | Free |
| Special Rate of Duty (Column 1 - Special) | N/A |
| Column 2 Rate of Duty | 30% |
| Quota Quantity | N/A |
| Additional Duties | N/A |
Overview
This classification pertains to medicaments primarily affecting the central nervous system, specifically those containing acetaminophen or its salts, that are not formulated for oral suspension. These products are intended for therapeutic or prophylactic uses and are presented in measured doses or in forms suitable for retail sale, excluding those designated for direct oral suspension.
This category is distinguished from its sibling, 3004.90.92.31 ("For oral suspension"), by the physical form and intended administration route of the medicament. While both involve acetaminophen-containing analgesics, this category excludes preparations specifically designed to be dissolved or diluted for oral ingestion, such as powders or granules intended for suspension. Instead, it typically encompasses solid dosage forms like tablets, capsules, or potentially liquids not intended for suspension.
As this is a leaf node within the HTS classification, there are no further subcategories to introduce. The classification ends with the specific criteria of containing acetaminophen or its salts and not being for oral suspension, alongside the overarching requirements of being a medicament for therapeutic or prophylactic use in measured doses or for retail sale and primarily affecting the central nervous system as an analgesic, antipyretic, or nonhormonal anti-inflammatory agent.